{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:23:34Z","timestamp":1767705814808,"version":"3.37.3"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100003200","name":"Ministry of Science, Technology and Innovation (MOSTI), Malaysia","doi-asserted-by":"publisher","award":["06-01-04-SF1673","FRGS 02-01-15-1686FR"],"award-info":[{"award-number":["06-01-04-SF1673","FRGS 02-01-15-1686FR"]}],"id":[{"id":"10.13039\/501100003200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"publisher","award":["RUGS GP IPS\/2014\/9432600"],"award-info":[{"award-number":["RUGS GP IPS\/2014\/9432600"]}],"id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chronic morphine stimulates prolonged stimulation of opioid receptors,\nespecially \u03bc-opioid subtype (MOR), which in turn signals cellular adaptation. However, the\nsudden termination of the use of morphine after chronic intake causes the withdrawal syndrome.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>Hence, this study was designed to find an alternative treatment for morphine\nwithdrawal using the alkaloid leaf extract of Erythroxylum cuneatum (E. cuneatum) for the\ntreatment of morphine-exposed neuroblastoma cell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>SK-N-SH, a commercialised neuroblastoma cell line, was used in two separate study\ndesigns; the antagonistic and pre-treatment of morphine. The antagonistic treatment was conducted\nthrough concurrent exposure of the cells to morphine and E. cuneatum or morphine and methadone\nfor 24 hrs. The pre-treatment design was carried out by exposing the cells to morphine for 24 hrs,\nfollowed by 24 hrs exposure to E. cuneatum or methadone. The cytosolic fraction was collected\nand assessed for proteins expression involved in cellular adaptation, including mitogen-activated\nprotein (MAP)\/extracellular signal-regulated (ERK) kinase 1\/2 (MEK 1\/2), extracellular signalregulated\nkinase 2 (ERK 2), cAMP-dependent protein kinase (PKA) and protein kinases C (PKC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The antagonistic treatment showed the normal level of MEK 1\/2, ERK 2, PKA and PKC\nby the combination treatment of morphine and E. cuneatum, comparable to the combination of\nmorphine and methadone. Neuroblastoma cells exposed to morphine pre-treatment expressed a\nhigh level of MEK 1\/2, ERK 2, PKA and PKC, while the treatments with E. cuneatum and methadone\nnormalised the expression of the cellular adaptation proteins.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>E. cuneatum exerted anti-addiction properties by lowering the levels of cellular adaptation\nproteins it\u2019s effects is comparable to that of methadone (an established anti-addiction drug).<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871524922666220516151121","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T07:55:20Z","timestamp":1652774120000},"page":"108-117","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["<i>Erythroxylum cuneatum<\/i> Prevented Cellular Adaptation in Morphineinduced\nNeuroblastoma Cells"],"prefix":"10.2174","volume":"22","author":[{"given":"Mohamad Aris Mohd","family":"Moklas","sequence":"first","affiliation":[{"name":"Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra\nMalaysia, 43400 Serdang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor Azuin","family":"Suliman","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universiti Sultan Zainal Abidin, Kampus Kota, Jalan Sultan Mahmud, 20400 Kuala Terengganu,\nTerengganu, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che Norma Mat","family":"Taib","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra\nMalaysia, 43400 Serdang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Taufik","family":"Hidayat Baharuldin","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra\nMalaysia, 43400 Serdang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa Samaila","family":"Chiroma","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Faculty of Basic Medical Sciences, University of\nMaiduguri, Borno State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","volume":"125","author":"Anand K.J.","year":"2010","unstructured":"Anand K.J.; Willson D.F.; Berger J.; Harrison R.; Meert K.L.; Zimmerman J.; Carcillo J.; Newth C.J.; Prodhan P.; Dean J.M.; Nicholson C.; Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics 2010,125(5),e1208-e1225","journal-title":"Pediatrics"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1523\/JNEUROSCI.0062-05.2005","volume":"25","author":"McClung C.A.","year":"2005","unstructured":"McClung C.A.; Nestler E.J.; Zachariou V.; Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J Neurosci 2005,25(25),6005-6015","journal-title":"J Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","volume":"81","author":"Williams J.T.","year":"2001","unstructured":"Williams J.T.; Christie M.J.; Manzoni O.; Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001,81(1),299-343","journal-title":"Physiol Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/phrs.2002.0962","volume":"45","author":"Nakai T.","year":"2002","unstructured":"Nakai T.; Hayashi M.; Ichihara K.; Wakabayashi H.; Hoshi K.; Noradrenaline release in rat locus coeruleus is regulated by both opioid and &#x3B1;(2) -adrenoceptors. Pharmacol Res 2002,45(5),407-412","journal-title":"Pharmacol Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cub.2016.09.010","volume":"26","author":"Xie K.","year":"2016","unstructured":"Xie K.; Colgan L.A.; Dao M.T.; Muntean B.S.; Sutton L.P.; Orlandi C.; Boye S.L.; Boye S.E.; Shih C.C.; Li Y.; Xu B.; Smith R.G.; Yasuda R.; Martemyanov K.A.; NF1 is a direct G protein effector essential for opioid signaling to ras in the striatum. Curr Biol 2016,26(22),2992-3003","journal-title":"Curr Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-neuro-080317-062155","volume":"41","author":"Monday H.R.","year":"2018","unstructured":"Monday H.R.; Younts T.J.; Castillo P.E.; Long-term plasticity of neurotransmitter release: Emerging mechanisms and contributions to brain function and disease. Annu Rev Neurosci 2018,41(1),299-322","journal-title":"Annu Rev Neurosci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2005.08.025","volume":"522","author":"Cerezo M.","year":"2005","unstructured":"Cerezo M.; Milan&#xE9;s M.V.; Laorden M.L.; Alterations in protein kinase A and different protein kinase C isoforms in the heart during morphine withdrawal. Eur J Pharmacol 2005,522(1-3),9-19","journal-title":"Eur J Pharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0014-2999(95)00370-Z","volume":"284","author":"Tokuyama S.","year":"1995","unstructured":"Tokuyama S.; Feng Y.; Wakabayashi H.; Ho I.K.; Possible involvement of protein kinases in physical dependence on opioids: Studies using protein kinase inhibitors, H-7 and H-8. Eur J Pharmacol 1995,284(1-2),101-107","journal-title":"Eur J Pharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.neuropharm.2006.03.028","volume":"51","author":"Cao J.L.","year":"2006","unstructured":"Cao J.L.; Liu H.L.; Wang J.K.; Zeng Y.M.; Cross talk between nitric oxide and ERK1\/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats. Neuropharmacology 2006,51(2),315-326","journal-title":"Neuropharmacology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/10826084.2017.1385630","volume":"53","author":"Ali N.","year":"2018","unstructured":"Ali N.; Aziz S.A.; Nordin S.; Mi N.C.; Abdullah N.; Paranthaman V.; Mahmud M.; Yee A.; Danaee M.; Evaluation of methadone treatment in Malaysia: Findings from the malaysian methadone treatment outcome study (MyTOS). Subst Use Misuse 2018,53(2),239-248","journal-title":"Subst Use Misuse"},{"key":"ref=11","first-page":"224","author":"Abadinsky H.","year":"2010","unstructured":"Abadinsky H.;  Drug use and abuse; A comprehensive introduction 2010,224-290","journal-title":"Drug use and abuse; A comprehensive introduction"},{"key":"ref=12","first-page":"428","volume":"62","author":"Sadovsky R.","year":"2000","unstructured":"Sadovsky R.; Public health issue: Methadone maintenance therapy. Am Fam Physician 2000,62(2),428-432","journal-title":"Am Fam Physician"},{"key":"ref=13","first-page":"1","volume":"12","author":"Leavitt S.B.","unstructured":"Leavitt S.B.; Methadone dosing"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3517209","DOI":"10.1155\/2016\/3517209","volume":"2016","author":"Suliman N.A.","year":"2016","unstructured":"Suliman N.A.; Mohd Moklas M.A.; Mat Taib C.N.; Adenan M.I.; Hidayat Baharuldin M.T.; Basir R.; Amom Z.; Morphine antidependence of Erythroxylum cuneatum (Miq.) Kurz in neurotransmission processes In Vitro. Evid Based Complement Alternat Med 2016,2016,3517209","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=15","first-page":"20","volume":"1","author":"Zaki M.A.A.","year":"2017","unstructured":"Zaki M.A.A.; Moklas M.A.M.; Baharuldin M.T.H.; Adenan M.I.; Jamil M.F.A.; Taib C.N.M.J.; \nIn vitro study on anti-withdrawal properties of Erythroxylum cuneatum (Mig.) Kurz leaf alkaloid extract. Nat Prod Pharmaco Res 2017,1(1),20-24","journal-title":"Nat Prod Pharmaco Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"Al-Hasani R.","year":"2011","unstructured":"Al-Hasani R.; Bruchas M.R.; Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 2011,115(6),1363-1381","journal-title":"Anesthesiology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/jnr.22326","volume":"88","author":"Lin X.","year":"2010","unstructured":"Lin X.; Wang Q.; Ji J.; Yu L.C.; Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area of rats. J Neurosci Res 2010,88(7),1595-1604","journal-title":"J Neurosci Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"18677","DOI":"10.1074\/jbc.273.30.18677","volume":"273","author":"Lefkowitz R.J.","year":"1998","unstructured":"Lefkowitz R.J.; G protein-coupled receptors. III. New roles for receptor kinases and &#x3B2;-arrestins in receptor signaling and desensitization. J Biol Chem 1998,273(30),18677-18680","journal-title":"J Biol Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jep.2013.03.078","volume":"148","author":"Jamil M.F.A.","year":"2013","unstructured":"Jamil M.F.A.; Subki M.F.M.; Lan T.M.; Majid M.I.A.; Adenan M.I.; The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell. J Ethnopharmacol 2013,148(1),135-143","journal-title":"J Ethnopharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev.med.55.091902.103730","volume":"55","author":"Chao J.","year":"2004","unstructured":"Chao J.; Nestler E.J.; Molecular neurobiology of drug addiction. Annu Rev Med 2004,55(1),113-132","journal-title":"Annu Rev Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.pain.2005.09.006","volume":"118","author":"Cao J.L.","year":"2005","unstructured":"Cao J.L.; He J.H.; Ding H.L.; Zeng Y.M.; Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain 2005,118(3),336-349","journal-title":"Pain"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev.pharmtox.42.082701.145401","volume":"42","author":"Adams J.P.","year":"2002","unstructured":"Adams J.P.; Sweatt J.D.; Molecular psychology: Roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 2002,42(1),135-163","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1242\/jeb.00220","volume":"206","author":"Cowan K.J.","year":"2003","unstructured":"Cowan K.J.; Storey K.B.; Mitogen-activated protein kinases: New signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 2003,206(Pt 7),1107-1115","journal-title":"J Exp Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1210\/en.2007-0510","volume":"148","author":"N&#xFA;&#xF1;ez C.","year":"2007","unstructured":"N&#xFA;&#xF1;ez C.; Laorden M.L.; Milan&#xE9;s M.V.; Regulation of serine (Ser)-31 and Ser40 tyrosine hydroxylase phosphorylation during morphine withdrawal in the hypothalamic paraventricular nucleus and nucleus tractus solitarius-A2 cell group: Role of ERK1\/2. Endocrinology 2007,148(12),5780-5793","journal-title":"Endocrinology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(01)02340-0","volume":"316","author":"Tso P.H.","year":"2001","unstructured":"Tso P.H.; Wong Y.H.; Role of extracellular signal-regulated kinases in opioid-induced adenylyl cyclase superactivation in human embryonic kidney 293 cells. Neurosci Lett 2001,316(1),13-16","journal-title":"Neurosci Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.tips.2004.02.005","volume":"25","author":"Nestler E.J.","year":"2004","unstructured":"Nestler E.J.; Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 2004,25(4),210-218","journal-title":"Trends Pharmacol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0173(01)00057-1","volume":"38","author":"Liu J.G.","year":"2001","unstructured":"Liu J.G.; Anand K.J.S.; Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 2001,38(1-2),1-19","journal-title":"Brain Res Brain Res Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1471-4159.1998.70020635.x","volume":"70","author":"Belcheva M.M.","year":"1998","unstructured":"Belcheva M.M.; Vogel Z.; Ignatova E.; Avidor-Reiss T.; Zippel R.; Levy R.; Young E.C.; Barg J.; Coscia C.J.; Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J Neurochem 1998,70(2),635-645","journal-title":"J Neurochem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1471-4159.2009.06156.x","volume":"110","author":"Miyatake M.","year":"2009","unstructured":"Miyatake M.; Rubinstein T.J.; McLennan G.P.; Belcheva M.M.; Coscia C.J.; Inhibition of EGF-induced ERK\/MAP kinase-mediated astrocyte proliferation by &#x3BC; opioids: Integration of G protein and &#x3B2;-arrestin 2-dependent pathways. J Neurochem 2009,110(2),662-674","journal-title":"J Neurochem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"27662","DOI":"10.1074\/jbc.M502593200","volume":"280","author":"Belcheva M.M.","year":"2005","unstructured":"Belcheva M.M.; Clark A.L.; Haas P.D.; Serna J.S.; Hahn J.W.; Kiss A.; Coscia C.J.; &#x3BC; and &#x3BA; opioid receptors activate ERK\/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 2005,280(30),27662-27669","journal-title":"J Biol Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2006.04.001","volume":"539","author":"Asensio V.J.","year":"2006","unstructured":"Asensio V.J.; Miralles A.; Garc&#xED;a-Sevilla J.A.; Stimulation of mitogen-activated protein kinase kinases (MEK1\/2) by &#x3BC;-, &#x3B4;- and &#x3BA;-opioid receptor agonists in the rat brain: Regulation by chronic morphine and opioid withdrawal. Eur J Pharmacol 2006,539(1-2),49-56","journal-title":"Eur J Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/jpet.109.152157","volume":"331","author":"Macey T.A.","year":"2009","unstructured":"Macey T.A.; Bobeck E.N.; Hegarty D.M.; Aicher S.A.; Ingram S.L.; Morgan M.M.; Extracellular signal-regulated kinase 1\/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat. J Pharmacol Exp Ther 2009,331(2),412-418","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/FBP.0b013e32832ec57e","volume":"20","author":"Hofford R.S.","year":"2009","unstructured":"Hofford R.S.; Hodgson S.R.; Roberts K.W.; Bryant C.D.; Evans C.J.; Eitan S.; Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal. Behav Pharmacol 2009,20(7),576-583","journal-title":"Behav Pharmacol"},{"key":"ref=34","first-page":"1","volume":"53","author":"Ferguson S.S.","year":"2001","unstructured":"Ferguson S.S.; Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 2001,53(1),1-24","journal-title":"Pharmacol Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1096\/fasebj.4.11.2165947","volume":"4","author":"Hausdorff W.P.","year":"1990","unstructured":"Hausdorff W.P.; Caron M.G.; Lefkowitz R.J.; Turning off the signal: Desensitization of beta-adrenergic receptor function. FASEB J 1990,4(11),2881-2889","journal-title":"FASEB J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1476-5381.1995.tb17222.x","volume":"116","author":"Smart D.","year":"1995","unstructured":"Smart D.; Lambert D.G.; Desensitization of the &#x3BC;-opioid activation of phospholipase C in SH-SY5Y cells: The role of protein kinases C and A and Ca(2+)-activated K+ currents. Br J Pharmacol 1995,116(6),2655-2660","journal-title":"Br J Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0014-2999(95)00871-3","volume":"300","author":"Fundytus M.E.","year":"1996","unstructured":"Fundytus M.E.; Coderre T.J.; Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur J Pharmacol 1996,300(3),173-181","journal-title":"Eur J Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0006-8993(94)90224-0","volume":"650","author":"Narita M.","year":"1994","unstructured":"Narita M.; Makimura M.; Feng Y.; Hoskins B.; Ho I.K.; Influence of chronic morphine treatment on protein kinase C activity: Comparison with butorphanol and implication for opioid tolerance. Brain Res 1994,650(1),175-179","journal-title":"Brain Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0304-3959(95)00023-L","volume":"61","author":"Mayer D.J.","year":"1995","unstructured":"Mayer D.J.; Mao J.; Price D.D.; The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 1995,61(3),365-374","journal-title":"Pain"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pain.2004.04.004","volume":"110","author":"Sweitzer S.M.","year":"2004","unstructured":"Sweitzer S.M.; Wong S.M.; Tjolsen A.; Allen C.P.; Mochly-Rosen D.; Kendig J.J.; Exaggerated nociceptive responses on morphine withdrawal: Roles of protein kinase C &#x3B5; and &#x3B3;. Pain 2004,110(1-2),281-289","journal-title":"Pain"}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871524922666220516151121","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204864\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871524922666220516151121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T11:50:11Z","timestamp":1665402611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204864\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871524922666220516151121","relation":{},"ISSN":["1871-5249"],"issn-type":[{"type":"print","value":"1871-5249"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}